Acrivon Therapeutics (ACRV) Return on Capital Employed [ROCE] (2022 - 2026)
Acrivon Therapeutics' Return on Capital Employed [ROCE] came in at -85.17% for Q2 2026, down 23.89 percentage points from -61.29% a year earlier and down 8.72 percentage points from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics' Return on Capital Employed [ROCE] was -57.03%, up 2.35 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a three-year change of -33.26 percentage points (FY2022 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -59.38% in FY2024 (-13.56 pp), -45.82% in FY2023 (-22.05 pp) and -23.77% in FY2022.
- The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2022.
- Year-over-year, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -12.66 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 4.58 percentage points), and the weakest in Q1 2024 (a drop of 35.05 percentage points).
- Business Quant data shows ACRV's Return on Capital Employed [ROCE] at -76.45% (Q1 2026), -69.03% (Q4 2025) and -64.90% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Acrivon Therapeutics | 67.27 Mn | -368.26 Mn | - | -85.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85.17% |
| Mar 31, 2026 | -76.45% |
| Dec 31, 2025 | -69.03% |
| Sep 30, 2025 | -64.90% |
| Jun 30, 2025 | -61.29% |
| Mar 31, 2025 | -53.89% |
| Dec 31, 2024 | -47.34% |
| Sep 30, 2024 | -41.05% |
| Jun 30, 2024 | -46.45% |
| Mar 31, 2024 | -58.48% |
| Dec 31, 2023 | -51.08% |
| Sep 30, 2023 | -38.28% |
| Jun 30, 2023 | -31.27% |
| Mar 31, 2023 | -23.43% |
| Dec 31, 2022 | -25.52% |
API Access
Acrivon Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();